These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24025401)

  • 61. Virucidal activity of human α- and β-defensins against hepatitis C virus genotype 4.
    Mattar EH; Almehdar HA; Uversky VN; Redwan EM
    Mol Biosyst; 2016 Aug; 12(9):2785-97. PubMed ID: 27327492
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Novel thioglycosyl analogs of glycosyltransferase substrates as antiviral compounds against classical swine fever virus and hepatitis C virus.
    Pastuch-Gawolek G; Chaubey B; Szewczyk B; Krol E
    Eur J Med Chem; 2017 Sep; 137():247-262. PubMed ID: 28601004
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The flavonoid apigenin inhibits hepatitis C virus replication by decreasing mature microRNA122 levels.
    Shibata C; Ohno M; Otsuka M; Kishikawa T; Goto K; Muroyama R; Kato N; Yoshikawa T; Takata A; Koike K
    Virology; 2014 Aug; 462-463():42-8. PubMed ID: 25092460
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antiviral activity of glycyrrhizin against hepatitis C virus in vitro.
    Matsumoto Y; Matsuura T; Aoyagi H; Matsuda M; Hmwe SS; Date T; Watanabe N; Watashi K; Suzuki R; Ichinose S; Wake K; Suzuki T; Miyamura T; Wakita T; Aizaki H
    PLoS One; 2013; 8(7):e68992. PubMed ID: 23874843
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Structure-activity studies of (-)-epigallocatechin gallate derivatives as HCV entry inhibitors.
    Bhat R; Adam AT; Lee JJ; Deloison G; Rouillé Y; Séron K; Rotella DP
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4162-5. PubMed ID: 25103601
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pan-genotypic Hepatitis C Virus Inhibition by Natural Products Derived from the Wild Egyptian Artichoke.
    Elsebai MF; Koutsoudakis G; Saludes V; Pérez-Vilaró G; Turpeinen A; Mattila S; Pirttilä AM; Fontaine-Vive F; Mehiri M; Meyerhans A; Diez J
    J Virol; 2016 Feb; 90(4):1918-30. PubMed ID: 26656684
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Polyanionic carbosilane dendrimers prevent hepatitis C virus infection in cell culture.
    Sepúlveda-Crespo D; Jiménez JL; Gómez R; De La Mata FJ; Majano PL; Muñoz-Fernández MÁ; Gastaminza P
    Nanomedicine; 2017 Jan; 13(1):49-58. PubMed ID: 27562210
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Potent virucidal activity of honeybee "Apis mellifera" venom against Hepatitis C Virus.
    Sarhan M; El-Bitar AMH; Hotta H
    Toxicon; 2020 Dec; 188():55-64. PubMed ID: 33068557
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Polyoxometalate exerts broad-spectrum activity against human respiratory viruses hampering viral entry.
    Arduino I; Francese R; Civra A; Feyles E; Argenziano M; Volante M; Cavalli R; Mougharbel AM; Kortz U; Donalisio M; Lembo D
    Antiviral Res; 2024 Jun; 226():105897. PubMed ID: 38685531
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Development of a drug assay system with hepatitis C virus genome derived from a patient with acute hepatitis C.
    Mori K; Ueda Y; Ariumi Y; Dansako H; Ikeda M; Kato N
    Virus Genes; 2012 Jun; 44(3):374-81. PubMed ID: 22252251
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Characterization and structure-activity relationship study of iminodipyridinopyrimidines as novel hepatitis C virus inhibitor.
    Park DS; Jo E; Choi J; Lee M; Kim S; Kim HY; Nam J; Ahn S; Hwang JY; Windisch MP
    Eur J Med Chem; 2017 Nov; 140():65-73. PubMed ID: 28923387
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Supercritical fluid extraction of heather (Calluna vulgaris) and evaluation of anti-hepatitis C virus activity of the extracts.
    García-Risco MR; Vázquez E; Sheldon J; Steinmann E; Riebesehl N; Fornari T; Reglero G
    Virus Res; 2015 Feb; 198():9-14. PubMed ID: 25550074
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Screening the anti infectivity potentials of native N- and C-lobes derived from the camel lactoferrin against hepatitis C virus.
    Redwan EM; El-Fakharany EM; Uversky VN; Linjawi MH
    BMC Complement Altern Med; 2014 Jul; 14():219. PubMed ID: 24993815
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Phenothiazines inhibit hepatitis C virus entry, likely by increasing the fluidity of cholesterol-rich membranes.
    Chamoun-Emanuelli AM; Pecheur EI; Simeon RL; Huang D; Cremer PS; Chen Z
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2571-81. PubMed ID: 23529728
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Synthesis and In Vitro anti-HCV and Antitumor Evaluation of Schisandronic Acid Derivatives.
    Zhang KX; Qian XJ; Zheng W; Cai MC; Ma Y; Zhang DZ; Yu SC; Meng QG; Jin YS
    Med Chem; 2021; 17(9):974-982. PubMed ID: 32819233
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A central hydrophobic E1 region controls the pH range of hepatitis C virus membrane fusion and susceptibility to fusion inhibitors.
    Banda DH; Perin PM; Brown RJP; Todt D; Solodenko W; Hoffmeyer P; Kumar Sahu K; Houghton M; Meuleman P; Müller R; Kirschning A; Pietschmann T
    J Hepatol; 2019 Jun; 70(6):1082-1092. PubMed ID: 30769006
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A cinnamon-derived procyanidin type A compound inhibits hepatitis C virus cell entry.
    Fauvelle C; Lambotin M; Heydmann L; Prakash E; Bhaskaran S; Vishwaraman M; Baumert TF; Moog C
    Hepatol Int; 2017 Sep; 11(5):440-445. PubMed ID: 28698985
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Synthesis, biological evaluation and mode of action studies of novel amidinourea inhibitors of hepatitis C virus (HCV).
    Magri A; Mokrane O; Lauder K; Patel AH; Castagnolo D
    Bioorg Med Chem Lett; 2019 Mar; 29(5):724-728. PubMed ID: 30661824
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Anti-RNA virus activity of polyoxometalates.
    Shigeta S; Mori S; Yamase T; Yamamoto N; Yamamoto N
    Biomed Pharmacother; 2006 Jun; 60(5):211-9. PubMed ID: 16737794
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [The ability of small interfering RNA oligonucleotides to decrease the infective activity of hepatitis C virus in the cell cultures].
    Bavykin AS; Mishin DV; Karpukhin AV; Deriabin PG
    Vopr Virusol; 2012; 57(2):32-4. PubMed ID: 22834145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.